Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Treatment of shock following myocardial infarction.

The Journal of the Oklahoma State Medical Association

Cohn JN.
PMID: 5406885
J Okla State Med Assoc. 1969 Dec;62(12):564-7.

No abstract available.

Cite
Cohn JN. Treatment of shock following myocardial infarction. J Okla State Med Assoc. 1969;62(12):564-7
Cohn, J. N. (1969). Treatment of shock following myocardial infarction. The Journal of the Oklahoma State Medical Association, 62(12), 564-7.
Cohn, J N. "Treatment of shock following myocardial infarction." The Journal of the Oklahoma State Medical Association vol. 62,12 (1969): 564-7.
Cohn JN. Treatment of shock following myocardial infarction. J Okla State Med Assoc. 1969 Dec;62(12):564-7. PMID: 5406885.
Copy Download .nbib Format: NLM
[Current views on the use of sympathomimetic amines in shock caused by myocardial infarct].

Minerva medica

Guerricchio G.
PMID: 5548399
Minerva Med. 1971 Feb 14;62(13):586-91.

No abstract available.

Cite
Guerricchio G. Attuali vedute sull'impiego delle amine simpaticomimetiche nello shock da infarto miocardico. [Current views on the use of sympathomimetic amines in shock caused by myocardial infarct]. Minerva Med. 1971;62(13):586-91
Guerricchio, G. (1971). Attuali vedute sull'impiego delle amine simpaticomimetiche nello shock da infarto miocardico. [Current views on the use of sympathomimetic amines in shock caused by myocardial infarct]. Minerva medica, 62(13), 586-91.
Guerricchio, G. "Attuali vedute sull'impiego delle amine simpaticomimetiche nello shock da infarto miocardico." [Current views on the use of sympathomimetic amines in shock caused by myocardial infarct]. Minerva medica vol. 62,13 (1971): 586-91.
Guerricchio G. Attuali vedute sull'impiego delle amine simpaticomimetiche nello shock da infarto miocardico. [Current views on the use of sympathomimetic amines in shock caused by myocardial infarct]. Minerva Med. 1971 Feb 14;62(13):586-91. Italian. PMID: 5548399.
Copy Download .nbib Format: NLM
Pharmacologic treatment of cardiogenic shock.

The Journal of the Kentucky Medical Association

Mc Martin DE, Masden R, Flowers N.
PMID: 1127303
J Ky Med Assoc. 1975 Feb;73(2):100-2.

No abstract available.

Cite
Mc Martin DE, Masden R, Flowers N. Pharmacologic treatment of cardiogenic shock. J Ky Med Assoc. 1975;73(2):100-2
Mc Martin, D. E., Masden, R., & Flowers, N. (1975). Pharmacologic treatment of cardiogenic shock. The Journal of the Kentucky Medical Association, 73(2), 100-2.
Mc Martin, D E, et al. "Pharmacologic treatment of cardiogenic shock." The Journal of the Kentucky Medical Association vol. 73,2 (1975): 100-2.
Mc Martin DE, Masden R, Flowers N. Pharmacologic treatment of cardiogenic shock. J Ky Med Assoc. 1975 Feb;73(2):100-2. PMID: 1127303.
Copy Download .nbib Format: NLM
Cardiogenic shock.

Lancet (London, England)

Piovan D, Magnolfi G, Ferrari M, Volta SD.
PMID: 11089851
Lancet. 2000 Nov 11;356(9242):1687-8. doi: 10.1016/S0140-6736(05)70396-2.

No abstract available.

Cite
Piovan D, Magnolfi G, Ferrari M, et al. Cardiogenic shock. Lancet. 2000;356(9242):1687-8doi: 10.1016/S0140-6736(05)70396-2.
Piovan, D., Magnolfi, G., Ferrari, M., & Volta, S. D. (2000). Cardiogenic shock. Lancet (London, England), 356(9242), 1687-8. https://doi.org/10.1016/S0140-6736(05)70396-2
Piovan, D, et al. "Cardiogenic shock." Lancet (London, England) vol. 356,9242 (2000): 1687-8. doi: https://doi.org/10.1016/S0140-6736(05)70396-2
Piovan D, Magnolfi G, Ferrari M, Volta SD. Cardiogenic shock. Lancet. 2000 Nov 11;356(9242):1687-8. doi: 10.1016/S0140-6736(05)70396-2. PMID: 11089851.
Copy Download .nbib Format: NLM
A 59-Year-Old Man in Refractory Shock.

Chest

Kwon M, Debella YT, Moss JE, Paniagua O, Diaz-Gomez JL.
PMID: 30290954
Chest. 2018 Oct;154(4):e93-e96. doi: 10.1016/j.chest.2018.04.050.

No abstract available.

Cite
Kwon M, Debella YT, Moss JE, et al. A 59-Year-Old Man in Refractory Shock. Chest. 2018;154(4):e93-e96doi: 10.1016/j.chest.2018.04.050.
Kwon, M., Debella, Y. T., Moss, J. E., Paniagua, O., & Diaz-Gomez, J. L. (2018). A 59-Year-Old Man in Refractory Shock. Chest, 154(4), e93-e96. https://doi.org/10.1016/j.chest.2018.04.050
Kwon, Minkyung, et al. "A 59-Year-Old Man in Refractory Shock." Chest vol. 154,4 (2018): e93-e96. doi: https://doi.org/10.1016/j.chest.2018.04.050
Kwon M, Debella YT, Moss JE, Paniagua O, Diaz-Gomez JL. A 59-Year-Old Man in Refractory Shock. Chest. 2018 Oct;154(4):e93-e96. doi: 10.1016/j.chest.2018.04.050. PMID: 30290954.
Copy Download .nbib Format: NLM
[Clinical results with streptokinase therapy in cardiogenic shock].

Folia haematologica (Leipzig, Germany : 1928)

Vogel G, Fiehring H.
PMID: 4114582
Folia Haematol Int Mag Klin Morphol Blutforsch. 1972;97(1):44-9.

No abstract available.

Cite
Vogel G, Fiehring H. Klinische Erfahrungen mit der Streptokinase-Behandlung beim kardiogenen Schock. [Clinical results with streptokinase therapy in cardiogenic shock]. Folia Haematol Int Mag Klin Morphol Blutforsch. 1972;97(1):44-9
Vogel, G., & Fiehring, H. (1972). Klinische Erfahrungen mit der Streptokinase-Behandlung beim kardiogenen Schock. [Clinical results with streptokinase therapy in cardiogenic shock]. Folia haematologica (Leipzig, Germany : 1928), 97(1), 44-9.
Vogel, G, and Fiehring, H. "Klinische Erfahrungen mit der Streptokinase-Behandlung beim kardiogenen Schock." [Clinical results with streptokinase therapy in cardiogenic shock]. Folia haematologica (Leipzig, Germany : 1928) vol. 97,1 (1972): 44-9.
Vogel G, Fiehring H. Klinische Erfahrungen mit der Streptokinase-Behandlung beim kardiogenen Schock. [Clinical results with streptokinase therapy in cardiogenic shock]. Folia Haematol Int Mag Klin Morphol Blutforsch. 1972;97(1):44-9. German. PMID: 4114582.
Copy Download .nbib Format: NLM
[Treatment of cardiogenic shock (author's transl)].

Kokyu to junkan. Respiration & circulation

Ayabe T.
PMID: 944943
Kokyu To Junkan. 1976 May;24(5):413-8.

No abstract available.

Cite
Ayabe T. [Treatment of cardiogenic shock (author's transl)]. Kokyu To Junkan. 1976;24(5):413-8
Ayabe, T. (1976). [Treatment of cardiogenic shock (author's transl)]. Kokyu to junkan. Respiration & circulation, 24(5), 413-8.
Ayabe, T. "[Treatment of cardiogenic shock (author's transl)]." Kokyu to junkan. Respiration & circulation vol. 24,5 (1976): 413-8.
Ayabe T. [Treatment of cardiogenic shock (author's transl)]. Kokyu To Junkan. 1976 May;24(5):413-8. Japanese. PMID: 944943.
Copy Download .nbib Format: NLM
Cardiogenic shock.

Emergency medical services

Krost WS.
PMID: 15481660
Emerg Med Serv. 2004 Sep;33(9):69-73, 78.

Cardiogenic shock is a pathophysiologic cascade that often leads to death. Although there has been a dramatic decrease in the cases of cardiogenic shock since the 1970s, the mortality rate of those patients who are diagnosed with cardiogenic shock...

Cite
Krost WS. Cardiogenic shock. Emerg Med Serv. 2004;33(9):69-73, 78
Krost, W. S. (2004). Cardiogenic shock. Emergency medical services, 33(9), 69-73, 78.
Krost, William S. "Cardiogenic shock." Emergency medical services vol. 33,9 (2004): 69-73, 78.
Krost WS. Cardiogenic shock. Emerg Med Serv. 2004 Sep;33(9):69-73, 78. PMID: 15481660.
Copy Download .nbib Format: NLM
Inotropic therapies in heart failure and cardiogenic shock: an educational review.

European heart journal. Acute cardiovascular care

DesJardin JT, Teerlink JR.
PMID: 34219157
Eur Heart J Acute Cardiovasc Care. 2021 Aug 24;10(6):676-686. doi: 10.1093/ehjacc/zuab047.

Reduced systolic function is central to the pathophysiology and clinical sequelae of acute decompensated heart failure (ADHF) with reduced ejection fraction and cardiogenic shock. These clinical entities are the final common pathway for marked deterioration of right or left...

Cite
DesJardin JT, Teerlink JR. Inotropic therapies in heart failure and cardiogenic shock: an educational review. Eur Heart J Acute Cardiovasc Care. 2021;10(6):676-686doi: 10.1093/ehjacc/zuab047.
DesJardin, J. T., & Teerlink, J. R. (2021). Inotropic therapies in heart failure and cardiogenic shock: an educational review. European heart journal. Acute cardiovascular care, 10(6), 676-686. https://doi.org/10.1093/ehjacc/zuab047
DesJardin, Jacqueline T, and Teerlink, John R. "Inotropic therapies in heart failure and cardiogenic shock: an educational review." European heart journal. Acute cardiovascular care vol. 10,6 (2021): 676-686. doi: https://doi.org/10.1093/ehjacc/zuab047
DesJardin JT, Teerlink JR. Inotropic therapies in heart failure and cardiogenic shock: an educational review. Eur Heart J Acute Cardiovasc Care. 2021 Aug 24;10(6):676-686. doi: 10.1093/ehjacc/zuab047. PMID: 34219157.
Copy Download .nbib Format: NLM
[Experimental and clinical experience in the use of vasoconstrictor and vasodilator agents in the intensive care and emergencies].

Vojnosanitetski pregled

Grabarić B, Pantelić D.
PMID: 4772855
Vojnosanit Pregl. 1973 Sep-Oct;30(5):452-4.

No abstract available.

Cite
Grabarić B, Pantelić D. Eksperimentalna i klinicka iskustva sa primjenom vazokonstriktora i vazodilatatora u intenzivnoj i urgentnoj terapiji. [Experimental and clinical experience in the use of vasoconstrictor and vasodilator agents in the intensive care and emergencies]. Vojnosanit Pregl. 1973;30(5):452-4
Grabarić, B., & Pantelić, D. (1973). Eksperimentalna i klinicka iskustva sa primjenom vazokonstriktora i vazodilatatora u intenzivnoj i urgentnoj terapiji. [Experimental and clinical experience in the use of vasoconstrictor and vasodilator agents in the intensive care and emergencies]. Vojnosanitetski pregled, 30(5), 452-4.
Grabarić, B, and Pantelić, D. "Eksperimentalna i klinicka iskustva sa primjenom vazokonstriktora i vazodilatatora u intenzivnoj i urgentnoj terapiji." [Experimental and clinical experience in the use of vasoconstrictor and vasodilator agents in the intensive care and emergencies]. Vojnosanitetski pregled vol. 30,5 (1973): 452-4.
Grabarić B, Pantelić D. Eksperimentalna i klinicka iskustva sa primjenom vazokonstriktora i vazodilatatora u intenzivnoj i urgentnoj terapiji. [Experimental and clinical experience in the use of vasoconstrictor and vasodilator agents in the intensive care and emergencies]. Vojnosanit Pregl. 1973 Sep-Oct;30(5):452-4. Serbian. PMID: 4772855.
Copy Download .nbib Format: NLM
Inotropic therapies in heart failure and cardiogenic shock: an educational review.

European heart journal. Acute cardiovascular care

DesJardin JT, Teerlink JR.
PMID: 34219157
Eur Heart J Acute Cardiovasc Care. 2021 Aug 24;10(6):676-686. doi: 10.1093/ehjacc/zuab047.

Reduced systolic function is central to the pathophysiology and clinical sequelae of acute decompensated heart failure (ADHF) with reduced ejection fraction and cardiogenic shock. These clinical entities are the final common pathway for marked deterioration of right or left...

Cite
DesJardin JT, Teerlink JR. Inotropic therapies in heart failure and cardiogenic shock: an educational review. Eur Heart J Acute Cardiovasc Care. 2021;10(6):676-686doi: 10.1093/ehjacc/zuab047.
DesJardin, J. T., & Teerlink, J. R. (2021). Inotropic therapies in heart failure and cardiogenic shock: an educational review. European heart journal. Acute cardiovascular care, 10(6), 676-686. https://doi.org/10.1093/ehjacc/zuab047
DesJardin, Jacqueline T, and Teerlink, John R. "Inotropic therapies in heart failure and cardiogenic shock: an educational review." European heart journal. Acute cardiovascular care vol. 10,6 (2021): 676-686. doi: https://doi.org/10.1093/ehjacc/zuab047
DesJardin JT, Teerlink JR. Inotropic therapies in heart failure and cardiogenic shock: an educational review. Eur Heart J Acute Cardiovasc Care. 2021 Aug 24;10(6):676-686. doi: 10.1093/ehjacc/zuab047. PMID: 34219157.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries